Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Fineqia Appoints Nicholas Thadaney, ex-CEO of Global Equity Capital Markets at TMX Group, to Advisory Board (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Novogen Limited NVGN

Healthcare Drug Manufacturers - Specialty & Generic
"Novogen Ltd is a pharmaceutical drug development based on a simple benzopyran chemical structure. It is an emerging oncology-focused biotechnology company that develops anti-cancer drugs."


NDAQ:NVGN - Post by User

Novogen Limited
<< Previous
 Bullboard Posts
User Avatar Image
(27)
•••
Post by radaredon Apr 15, 2015 2:22am
130 Views
Post# 23630647

Would have liked to have followed this a little closer

Would have liked to have followed this a little closer Like everything about this one except I don't own some of it. Cheers eom
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities